Suomija - suomių - Fimea (Suomen lääkevirasto)

wyeth lederle nordiska ab - estradiolum hemihydricum,trimegestonum - tabletti, päällystetty - 1 mg / 0.125 mg - trimegestoni ja estrogeeni

Suomija - suomių - Fimea (Suomen lääkevirasto)

wyeth lederle nordiska ab - trimegestonum,estradiolum - tabletti, päällystetty - trimegestoni ja estrogeeni

Suomija - suomių - Fimea (Suomen lääkevirasto)

wyeth lederle nordiska ab - levonorgestrelum,ethinylestradiolum - tabletti, kalvopäällysteinen - levonorgestreeli ja etinyyliestradioli

Europos Sąjunga - suomių - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.

Suomija - suomių - Fimea (Suomen lääkevirasto)

ayerst laboratories inc. wyeth ayerst laboratories - ecothiopati iodidum - jauhe silmätippoja varten - 0.6 mg/ml - ekotiopaatti

Suomija - suomių - Fimea (Suomen lääkevirasto)

ayerst laboratories inc. wyeth ayerst laboratories - ecothiopati iodidum - jauhe silmätippoja varten - 1.25 mg/ml - ekotiopaatti

Suomija - suomių - Fimea (Suomen lääkevirasto)

ayerst laboratories inc. wyeth ayerst laboratories - ecothiopati iodidum - jauhe silmätippoja varten - 2.5 mg/ml - ekotiopaatti

Europos Sąjunga - suomių - EMA (European Medicines Agency)

pfizer limited  - metaflumitsonia - ulkoloislääkkeet paikalliseen käyttöön, sis. hyönteismyrkyt - kissat - kirppupetosten hoito ja ehkäisy (ctenocephalides canis ja c. felis) kissalla. eläinlääkevalmistetta voidaan käyttää osana kirppu allergiadermatiitin (fad) hoitostrategiaa,.

Europos Sąjunga - suomių - EMA (European Medicines Agency)

pfizer limited  - metaflumizone, amitraz - ulkoloislääkkeet paikalliseen käyttöön, sis. hyönteismyrkyt - koirat - kirppujen (ctenocephalides canis ja c. felis), ja punkkeja (ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus, dermacentor reticulatus ja dermacentor variabilis), ja hoito demodikoosi (demodex spp. ) ja koirien (trichodectes canis). eläinlääkevalmistetta voidaan käyttää osana kirppu allergiadermatiitin (fad) hoitostrategiaa,.

Europos Sąjunga - suomių - EMA (European Medicines Agency)

pfizer europe ma eeig - etanersepti - arthritis, psoriatic; spondylitis, ankylosing; psoriasis - immunosuppressantit - nivelreuma;juveniili idiopaattinen arthritispsoriatic niveltulehdus;aksiaalinen spondyloartriitti;läiskäpsoriaasi;läiskäpsoriaasi lapsilla.